Does ERIBULIN Cause Myelosuppression? 520 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 520 reports of Myelosuppression have been filed in association with ERIBULIN (eribulin mesylate). This represents 10.3% of all adverse event reports for ERIBULIN.
520
Reports of Myelosuppression with ERIBULIN
10.3%
of all ERIBULIN reports
2
Deaths
380
Hospitalizations
How Dangerous Is Myelosuppression From ERIBULIN?
Of the 520 reports, 2 (0.4%) resulted in death, 380 (73.1%) required hospitalization, and 30 (5.8%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERIBULIN. However, 520 reports have been filed with the FAERS database.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
Anaemia (188)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ERIBULIN Alternatives Have Lower Myelosuppression Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE